In our study, we found that silencing of HHLA2 can inhibit the EMT process of pancreatic cancer cells, and the mechanism may be related to the regulation of EGFR/MAPK /mTOR/AKT/ERK1/2 signaling pathway. The gene discussed is MTOR; the disease is pancreatic neoplasm.